Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Omaveloxolone

EU orphan designation number: EU/3/18/2037   
Active ingredient: Omaveloxolone
Indication: Treatment of Friedreich's ataxia
Sponsor: Dr Stefan Blesse
Thierschstraße 3, 80538 München, Deutschland

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/06/2018 Orphan designation EMA/OD/033/18 (2018)4182 of 27/06/2018